Ferinject in Addition to pulmonary rehabilitation in patients with COPD and iron deficiency to improve Exercise tolerance (FACE II study) - Trial 2019-005005-43
Access comprehensive clinical trial information for 2019-005005-43 through Pure Global AI's free database. This phase not specified trial is sponsored by Consorci Mar Parc de Salut de Barcelona and is currently Ongoing. The study focuses on Chronic Obstructive Pulmonary Disease (COPD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Consorci Mar Parc de Salut de Barcelona
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
1. Cardiovascular, neurological, liver, kidney, musculoskeletal disorders or uncontrolled psychiatric disorders that prevent the practice of exercise.
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2019-005005-43
Non-Device Trial